AU540147B2 – Cyclopentanonealkenoic acid derivatives
– Google Patents
AU540147B2 – Cyclopentanonealkenoic acid derivatives
– Google Patents
Cyclopentanonealkenoic acid derivatives
Info
Publication number
AU540147B2
AU540147B2
AU69957/81A
AU6995781A
AU540147B2
AU 540147 B2
AU540147 B2
AU 540147B2
AU 69957/81 A
AU69957/81 A
AU 69957/81A
AU 6995781 A
AU6995781 A
AU 6995781A
AU 540147 B2
AU540147 B2
AU 540147B2
Authority
AU
Australia
Prior art keywords
cyclopentanonealkenoic
acid derivatives
derivatives
acid
cyclopentanonealkenoic acid
Prior art date
1980-04-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU69957/81A
Other versions
AU6995781A
(en
Inventor
John Bradshaw
Eric William Collington
Peter Hallett
Norman Frank Hayes
John Wallis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1980-04-30
Filing date
1981-04-29
Publication date
1984-11-01
1981-04-29
Application filed by Glaxo Group Ltd
filed
Critical
Glaxo Group Ltd
1981-11-05
Publication of AU6995781A
publication
Critical
patent/AU6995781A/en
1984-11-01
Application granted
granted
Critical
1984-11-01
Publication of AU540147B2
publication
Critical
patent/AU540147B2/en
2001-04-29
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
239000002253
acid
Substances
0.000
title
1
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P11/00—Drugs for disorders of the respiratory system
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P11/00—Drugs for disorders of the respiratory system
A61P11/08—Bronchodilators
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P27/00—Drugs for disorders of the senses
A61P27/02—Ophthalmic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P7/00—Drugs for disorders of the blood or the extracellular fluid
A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/08—Vasodilators for multiple indications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C17/00—Preparation of halogenated hydrocarbons
C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
C07D267/02—Seven-membered rings
C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D309/10—Oxygen atoms
C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
C07D333/12—Radicals substituted by halogen atoms or nitro or nitroso radicals
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
D—TEXTILES; PAPER
D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
D01F6/58—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
D01F6/62—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters
D01F6/625—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters derived from hydroxy-carboxylic acids, e.g. lactones
AU69957/81A
1980-04-30
1981-04-29
Cyclopentanonealkenoic acid derivatives
Ceased
AU540147B2
(en)
Applications Claiming Priority (4)
Application Number
Priority Date
Filing Date
Title
GB8014256
1980-04-30
GB8014256
1980-04-30
GB8100326
1981-01-07
GB8100326
1981-01-07
Publications (2)
Publication Number
Publication Date
AU6995781A
AU6995781A
(en)
1981-11-05
AU540147B2
true
AU540147B2
(en)
1984-11-01
Family
ID=26275368
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU69957/81A
Ceased
AU540147B2
(en)
1980-04-30
1981-04-29
Cyclopentanonealkenoic acid derivatives
Country Status (21)
Country
Link
US
(2)
US4342756A
(en)
JP
(2)
JPS5718671A
(en)
KR
(1)
KR850000214B1
(en)
AT
(1)
ATA191781A
(en)
AU
(1)
AU540147B2
(en)
BE
(1)
BE888645A
(en)
CH
(1)
CH646965A5
(en)
DE
(1)
DE3117087A1
(en)
DK
(1)
DK189881A
(en)
ES
(2)
ES501740A0
(en)
FI
(1)
FI78293C
(en)
FR
(1)
FR2481703B1
(en)
GB
(1)
GB2075503B
(en)
IE
(1)
IE51241B1
(en)
IL
(1)
IL62734A
(en)
IT
(1)
IT1170929B
(en)
NL
(1)
NL8102116A
(en)
NO
(1)
NO811470L
(en)
NZ
(1)
NZ196966A
(en)
PT
(1)
PT72951B
(en)
SE
(1)
SE8102731L
(en)
Families Citing this family (36)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
ES482357A1
(en)
*
1978-07-11
1980-08-16
Glaxo Group Ltd
Prostanoid compounds and compositions
US4438111A
(en)
1980-01-09
1984-03-20
Glaxo Group Limited
Prostanoid compounds and pharmaceutical formulations
ZA81114B
(en)
1980-01-09
1982-01-27
Glaxo Group Ltd
Prostanoid compounds and their preparation and pharmaceutical formalation
CA1191134A
(en)
*
1981-04-29
1985-07-30
Eric W. Collington
Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation
CA1190926A
(en)
*
1981-09-16
1985-07-23
Christopher J. Wallis
Aminocyclopentane esters and their preparation and pharmaceutical formulation
US4410521A
(en)
*
1981-09-16
1983-10-18
Glaxo Group Limited
Aminocyclopentane esters and pharmaceutical formulations
IL67041A
(en)
*
1981-10-29
1988-03-31
Glaxo Group Ltd
2-aminocyclopentane alkanoic and alkenoic acid esters,process for their preparation and pharmaceutical compositions containing them
GR77727B
(en)
*
1981-10-29
1984-09-25
Glaxo Group Ltd
US4837234A
(en)
*
1981-12-23
1989-06-06
National Research Development Corporation
Prostaglandins
GB2113678B
(en)
*
1981-12-23
1985-06-19
Nat Res Dev
Prostaglandins
GB2127406B
(en)
*
1982-09-16
1986-03-05
Glaxo Group Ltd
Piperidinlycyclopentanolheptenoic acid salt
AU576476B2
(en)
*
1982-09-16
1988-09-01
Glaxo Group Limited
Piperidinylcyclopentanol heptenoic acid salt
AT387220B
(en)
*
1982-10-28
1988-12-27
Glaxo Group Ltd
METHOD FOR PRODUCING AMINOCYCLOPENTANE ACIDS
GB8307099D0
(en)
*
1983-03-15
1983-04-20
Glaxo Group Ltd
Carbocyclic compounds
LU85528A1
(en)
*
1983-09-06
1985-04-29
Glaxo Group Ltd
AMINOCYCLOPENTANS AND THEIR PREPARATION PROCESS
GB2167404A
(en)
*
1984-10-26
1986-05-29
Glaxo Group Ltd
Prostanoid aminocyclopentane alkenoic acids and esters, their preparation and pharmaceutical formulation
GB8601985D0
(en)
*
1986-01-28
1986-03-05
Glaxo Group Ltd
Chemical process
GB8625326D0
(en)
*
1986-10-22
1986-11-26
Glaxo Group Ltd
Medicaments
GB8715333D0
(en)
*
1987-06-30
1987-08-05
Glaxo Group Ltd
Process
GB9720270D0
(en)
*
1997-09-25
1997-11-26
Pharmagene Lab Limited
Medicaments for the treatment of migraine
GB2330307A
(en)
*
1998-02-07
1999-04-21
Glaxo Group Ltd
EP4 Receptor antagonists as bone resorption inhibitors
US6414006B1
(en)
1998-10-15
2002-07-02
Merck Frosst Canada & Co.
Methods for inhibiting bone resorption
EP1442744B1
(en)
1999-08-10
2006-12-20
Glaxo Group Limited
EP4 receptor ligand and use against neuropathic pain, colon cancer, HIV and migrane
GB0124124D0
(en)
*
2001-10-08
2001-11-28
Medical Res Council
Methods of treatment
WO2003089002A1
(en)
*
2002-04-17
2003-10-30
Medical Research Council
Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia
GB0208785D0
(en)
*
2002-04-17
2002-05-29
Medical Res Council
Treatment methtods
WO2004071508A1
(en)
*
2003-02-14
2004-08-26
Medical Research Council
Ip receptor antagonists for the treatment of pathological uterine conditions
EP1924553A1
(en)
2005-08-08
2008-05-28
Argenta Discovery Limited
Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
JP2008193940A
(en)
*
2007-02-13
2008-08-28
Honda Motor Co Ltd
Method for purifying polyhydroxybutyrate
EP3686181A1
(en)
2013-01-30
2020-07-29
Ecolab USA Inc.
Hydrogen sulfide scavengers
US10308886B2
(en)
2015-04-22
2019-06-04
Ecolab Usa Inc.
Development of a novel high temperature stable scavenger for removal of hydrogen sulfide
CA2997083C
(en)
2015-09-08
2023-06-13
Ecolab Usa Inc.
Hydrocarbon soluble/dispersible hemiformals as hydrogen sulfide scavengers
US10584286B2
(en)
2015-09-08
2020-03-10
Ecolab Usa Inc.
Hydrogen sulfide scavengers
US10336950B2
(en)
2016-07-29
2019-07-02
Ecolab Usa Inc.
Antifouling and hydrogen sulfide scavenging compositions and methods
US10538710B2
(en)
2017-07-13
2020-01-21
Ecolab Usa Inc.
Hydrogen sulfide scavengers
WO2020154251A1
(en)
2019-01-23
2020-07-30
Ecolab Usa Inc.
Complete removal of solids during hydrogen sulfide scavenging operations using a scavenger and a michael acceptor
Family Cites Families (5)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB1553293A
(en)
1976-02-23
1979-09-26
Lepetit Spa
Azaprostaglandins
US4189606A
(en)
*
1976-02-23
1980-02-19
Gruppo Lepetit S.P.A.
13-Azaprostaglandins
ES482357A1
(en)
*
1978-07-11
1980-08-16
Glaxo Group Ltd
Prostanoid compounds and compositions
GB2028805B
(en)
*
1978-07-11
1982-11-03
Glaxo Group Ltd
Prostanoid compounds
US4239778A
(en)
*
1978-09-12
1980-12-16
The University Of Illinois Foundation
Azaprostanoic acid analogs and their use as inhibitors of platelet aggregation
1981
1981-04-28
IL
IL62734A
patent/IL62734A/en
unknown
1981-04-28
JP
JP6353781A
patent/JPS5718671A/en
active
Granted
1981-04-29
US
US06/258,721
patent/US4342756A/en
not_active
Expired – Fee Related
1981-04-29
AU
AU69957/81A
patent/AU540147B2/en
not_active
Ceased
1981-04-29
DK
DK189881A
patent/DK189881A/en
not_active
Application Discontinuation
1981-04-29
FI
FI811350A
patent/FI78293C/en
not_active
IP Right Cessation
1981-04-29
NZ
NZ196966A
patent/NZ196966A/en
unknown
1981-04-29
CH
CH280181A
patent/CH646965A5/en
not_active
IP Right Cessation
1981-04-29
KR
KR1019810001478A
patent/KR850000214B1/en
active
IP Right Grant
1981-04-29
GB
GB8113239A
patent/GB2075503B/en
not_active
Expired
1981-04-29
US
US06/258,737
patent/US4327092A/en
not_active
Expired – Fee Related
1981-04-29
NO
NO811470A
patent/NO811470L/en
unknown
1981-04-29
ES
ES501740A
patent/ES501740A0/en
active
Granted
1981-04-29
IT
IT48367/81A
patent/IT1170929B/en
active
1981-04-29
SE
SE8102731A
patent/SE8102731L/en
not_active
Application Discontinuation
1981-04-29
DE
DE19813117087
patent/DE3117087A1/en
active
Granted
1981-04-29
PT
PT72951A
patent/PT72951B/en
unknown
1981-04-29
AT
AT0191781A
patent/ATA191781A/en
not_active
IP Right Cessation
1981-04-29
NL
NL8102116A
patent/NL8102116A/en
not_active
Application Discontinuation
1981-04-29
IE
IE957/81A
patent/IE51241B1/en
unknown
1981-04-30
FR
FR8108660A
patent/FR2481703B1/en
not_active
Expired
1981-04-30
BE
BE0/204664A
patent/BE888645A/en
not_active
IP Right Cessation
1982
1982-03-26
ES
ES510838A
patent/ES510838A0/en
active
Granted
1982-10-29
JP
JP57190702A
patent/JPS5882723A/en
active
Granted
Also Published As
Publication number
Publication date
GB2075503B
(en)
1984-03-28
NL8102116A
(en)
1981-11-16
US4342756A
(en)
1982-08-03
IE810957L
(en)
1981-10-30
US4327092A
(en)
1982-04-27
IL62734A
(en)
1985-10-31
SE8102731L
(en)
1981-12-21
ES8207498A1
(en)
1982-09-16
DK189881A
(en)
1981-10-31
PT72951A
(en)
1981-05-01
JPH0314028B2
(en)
1991-02-25
FR2481703A1
(en)
1981-11-06
IT1170929B
(en)
1987-06-03
KR850000214B1
(en)
1985-03-06
DE3117087A1
(en)
1982-03-11
IT8148367D0
(en)
1981-04-29
JPS5718671A
(en)
1982-01-30
NZ196966A
(en)
1984-05-31
FI811350L
(en)
1981-10-31
BE888645A
(en)
1981-10-30
PT72951B
(en)
1983-06-15
KR830005187A
(en)
1983-08-03
JPS5882723A
(en)
1983-05-18
IE51241B1
(en)
1986-11-12
JPH0263054B2
(en)
1990-12-27
NO811470L
(en)
1981-11-02
GB2075503A
(en)
1981-11-18
ES501740A0
(en)
1982-09-16
ES8303386A1
(en)
1983-02-01
FI78293B
(en)
1989-03-31
IL62734A0
(en)
1981-06-29
FI78293C
(en)
1989-07-10
AU6995781A
(en)
1981-11-05
ATA191781A
(en)
1985-11-15
ES510838A0
(en)
1983-02-01
FR2481703B1
(en)
1985-08-02
CH646965A5
(en)
1984-12-28
Similar Documents
Publication
Publication Date
Title
AU540147B2
(en)
1984-11-01
Cyclopentanonealkenoic acid derivatives
AU542623B2
(en)
1985-02-28
1-hydroxyethyl-azole derivatives
AU557689B2
(en)
1987-01-08
1-sulfo-2-oxoazetidine derivatives
AU544723B2
(en)
1985-06-13
Imidazolylpropanol derivatives
AU540898B2
(en)
1984-12-06
17-disubstituted-androst-4-en-3-one derivatives
AU534878B2
(en)
1984-02-16
Amino-saccharide derivatives
AU544527B2
(en)
1985-06-06
Bis-carboxamide derivatives
AU543641B2
(en)
1985-04-26
Butenoic acid derivatives
AU554360B2
(en)
1986-08-21
S-triazinyl-aminofluorescein derivatives
AU545357B2
(en)
1985-07-11
Triazolo-benzodiazepine derivatives
AU551238B2
(en)
1986-04-24
1-hydroxy-2 -fluorocholecalciferol derivatives
AU1565783A
(en)
1983-12-22
Oxazoleacetic acid derivatives
AU544907B2
(en)
1985-06-20
Isonicotinanilide derivatives
AU538505B2
(en)
1984-08-16
Phenoxy-aminopropanol derivatives
AU540239B2
(en)
1984-11-08
2-guanidinothiazole derivatives
AU539443B2
(en)
1984-09-27
Phenoxybutyltriazole derivatives
AU6817281A
(en)
1981-09-17
2-penem-3-carboxylic acid derivatives
AU7876981A
(en)
1982-07-01
Clavulanic acid derivatives
AU6826581A
(en)
1981-09-17
Beta-aminoisothiazolylacetamido-3-cephem-4-carboxylic acid derivatives
AU558459B2
(en)
1987-01-29
Apovincaminic acid derivatives
AU539442B2
(en)
1984-09-27
Indol-3-acetic acid derivatives
AU526941B2
(en)
1983-02-10
Pyrazole-substituted oximino-cyano-acetamide derivatives
AU7912781A
(en)
1982-07-08
Monic acid derivatives
AU546228B2
(en)
1985-08-22
Fluoromethylthioacetic acid compounds
AU542504B2
(en)
1985-02-21
Nicotinic acid derivatives
None